Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024. 1. Discuss the data presented at ASCO 2024 on long-term follow-up of patients receiving ...
Please provide your email address to receive an email when new articles are posted on . Among experienced operators, prophylactic nitroglycerin did not prevent radial artery spasm during transradial ...
...and of course by 'prophylactic' I'm referring to a toothbrush.<BR><BR>I just had an encounter with someone using a toothbrush in the restroom here at work. It struck me that I've seen a lot of ...
PTCY offers improved progression-free and overall survival compared to ATG in MDS patients undergoing allo-HSCT. PTCY is associated with lower rates of grade 2 to 4 acute GVHD but has delayed ...
Significant variation exists in supportive care strategies for older adults with MDS and AML receiving less intensive therapy. Prophylactic platelet transfusions are common, but TXA use is limited due ...
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of ...
– Despite currently available treatment options, the majority of surveyed adults with HAE reported making tradeoffs in their daily lives due to the unexpected and unpredictable nature of HAE attacks – ...
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced that it has been awarded a $2.2 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results